Dog /
FDA CVM · 2025 release 452 reports on file

Basenji - FDA Adverse Event Profile

Adverse-event records for Basenji (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 48 36 24 12 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Basenji drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

With 452 reports on file, Basenji sits at #144 among dog breeds by volume; death-coded share is 5.5% (25 reports).

#144
most-reported dog breed
5.5%
death-coded report share
109
Vomiting - top reaction
6.0 yr
average age at report

Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.

Total Reports

452

FDA CVM filings

Deaths Reported

25

of 452 reports

Death Rate

5.5%

death-coded share

Avg Age at Report

6.0 yr

15.0 kg avg weight

Death-Coded Outcome Share

Basenji death-coded reports 5.5%
Cross-breed median

5.5% of 452 basenji reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 15.0 kg (33.1 lbs)

Top Reported Reactions

Vomiting 109
Lethargy (see also Central nervous system depression in 'Neurological') 42
Emesis 41
Diarrhoea 33
INEFFECTIVE, HEARTWORM LARVAE 28
Lack of efficacy (endoparasite) - heartworm 24
Seizure NOS 22
Lack of efficacy - NOS 22

Most Referenced Drugs

Milbemycin Oxime + Spinosad 86
Ivermectin + Pyrantel As Pamoate Salt 57
Afoxolaner 39
Spinosad 33
Moxidectin 23
Pyrantel Pamoate;Sarolaner 22
Fluralaner Chew Tablets 21
Milbemycin Oxime + Praziquantel 16

Outcome Breakdown

Recovered/Normal
175 (40.0%)
Outcome Unknown
125 (28.5%)
Ongoing
94 (21.5%)
Recovered with Sequela
19 (4.3%)
Died
14 (3.2%)
Euthanized
11 (2.5%)

Gender Distribution

Female 255 (56.4%)
Male 188 (41.6%)
Unknown 6 (1.3%)
Mixed 3 (0.7%)

Reports by Year

Year Reports Trend
2010 13
2011 13
2012 29
2013 23
2014 34
2015 35
2016 41
2017 42
2018 44
2019 48
2020 25
2021 20
2022 22
2023 19
2024 30
2025 14

Basenji Pet Health Insights

Basenji accounts for 452 FDA adverse event reports, ranking #144 by volume among dog breeds, with 25 reports (5.5%) coded as a death outcome. Mean age at report: 6.0 years, average weight 15.0 kg (33.1 lbs).

Top reported signs: Vomiting (109), Lethargy (see also Central nervous system depression in 'Neurological') (42), Emesis (41). Most-referenced drug: Milbemycin Oxime + Spinosad (86 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (57) and Afoxolaner (39).

Outcome coding on 438 status-recorded reports is dominated by Recovered/Normal (40.0%). Annual submissions ranged 2,010-2,025 across 16 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Basenji?
There are 452 adverse event reports involving Basenji in the FDA database, with 25 reports involving death (5.5% death rate). Basenji ranks #144 by report volume.
What are the most common adverse reactions reported for Basenji?
The most commonly reported adverse reactions for Basenji are Vomiting (109 reports), Lethargy (see also Central nervous system depression in 'Neurological') (42 reports), Emesis (41 reports), Diarrhoea (33 reports), INEFFECTIVE, HEARTWORM LARVAE (28 reports).
What drugs are most frequently associated with Basenji adverse events?
The drugs most frequently referenced in Basenji adverse event reports are Milbemycin Oxime + Spinosad (86 reports), Ivermectin + Pyrantel As Pamoate Salt (57 reports), Afoxolaner (39 reports), Spinosad (33 reports), Moxidectin (23 reports).
What is the average age of Basenji in adverse event reports?
The average age of Basenji at the time of adverse event reports is 6.0 years, with an average weight of 15.0 kg (33.1 lbs).
Does a high number of adverse event reports mean Basenji is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Basenji safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.